Sacral Neuromodulation Therapy for Urinary and Fecal Incontinence in Patients With Multiple Sclerosis: Report of 6 Cases and Literature Review.

Q1 Nursing
International journal of MS care Pub Date : 2023-07-01 Epub Date: 2023-02-08 DOI:10.7224/1537-2073.2022-027
Erika Thys, Kent Sasse
{"title":"Sacral Neuromodulation Therapy for Urinary and Fecal Incontinence in Patients With Multiple Sclerosis: Report of 6 Cases and Literature Review.","authors":"Erika Thys,&nbsp;Kent Sasse","doi":"10.7224/1537-2073.2022-027","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Urinary incontinence (UI) and fecal incontinence (FI) are challenging manifestations of multiple sclerosis (MS) that have historically been treated with limited success. Sacral neuromodulation (SNM) has provided successful resolution of UI and FI in the general population and in patients with neurologic conditions, including MS. We report on 6 patients with MS-related incontinence treated successfully with SNM and review the literature.</p><p><strong>Methods: </strong>Medical records were reviewed retrospectively to identify patients with MS seeking treatment for incontinence. Six patients were identified, and each is presented with follow-up assessment of the severity of UI or FI.</p><p><strong>Results: </strong>All 6 individuals with MS had severe incontinence that had been refractory to therapies that included medications and pelvic floor physical therapy. Five patients reported severe UI and 2 patients reported severe FI. Each patient was successfully treated with SNM, with large reductions of incontinence scores and improved quality of life.</p><p><strong>Conclusions: </strong>In this case series, SNM was effective as a treatment for UI and FI among patients with MS. These findings confirm other published series that have reported the success of SNM in patients with MS with incontinence. Sacral neuromodulation should be considered as a potential treatment option for patients with MS and UI and/or FI.</p>","PeriodicalId":14150,"journal":{"name":"International journal of MS care","volume":"25 4","pages":"163-167"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353694/pdf/i1537-2073-25-4-163.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of MS care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7224/1537-2073.2022-027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Urinary incontinence (UI) and fecal incontinence (FI) are challenging manifestations of multiple sclerosis (MS) that have historically been treated with limited success. Sacral neuromodulation (SNM) has provided successful resolution of UI and FI in the general population and in patients with neurologic conditions, including MS. We report on 6 patients with MS-related incontinence treated successfully with SNM and review the literature.

Methods: Medical records were reviewed retrospectively to identify patients with MS seeking treatment for incontinence. Six patients were identified, and each is presented with follow-up assessment of the severity of UI or FI.

Results: All 6 individuals with MS had severe incontinence that had been refractory to therapies that included medications and pelvic floor physical therapy. Five patients reported severe UI and 2 patients reported severe FI. Each patient was successfully treated with SNM, with large reductions of incontinence scores and improved quality of life.

Conclusions: In this case series, SNM was effective as a treatment for UI and FI among patients with MS. These findings confirm other published series that have reported the success of SNM in patients with MS with incontinence. Sacral neuromodulation should be considered as a potential treatment option for patients with MS and UI and/or FI.

脊髓神经调控治疗多发性硬化症患者大小便失禁6例报告及文献复习。
背景:尿失禁(UI)和大便失禁(FI)是多发性硬化症(MS)的挑战性表现,历来治疗效果有限。骶神经调控(SNM)在普通人群和包括MS在内的神经系统疾病患者中成功地解决了UI和FI。我们报告了6例用SNM成功治疗的MS相关失禁患者,并回顾了文献。方法:回顾性分析医疗记录,以确定寻求失禁治疗的MS患者。确定了6名患者,每个患者都接受了UI或FI严重程度的随访评估。结果:所有6名MS患者都有严重失禁,这些失禁对包括药物和盆底物理治疗在内的治疗是难治的。5名患者报告严重UI,2名患者报告重度FI。每个患者都成功地接受了SNM治疗,失禁评分大幅降低,生活质量得到改善。结论:在本病例系列中,SNM对MS患者的UI和FI是有效的治疗方法。这些发现证实了其他已发表的系列报道,即SNM在MS失禁患者中的成功。对于MS和UI和/或FI患者,应考虑将骶神经调控作为一种潜在的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International journal of MS care
International journal of MS care Nursing-Advanced and Specialized Nursing
CiteScore
3.00
自引率
0.00%
发文量
40
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信